Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

Published Date: 13 Dec 2024

Complete responses seen in 43% of patients in expansion cohort of EPCORE CLL-1 study

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.

2.

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

3.

Radiation from CT scans could account for 5% of all cancer cases a year, study suggests

4.

According to a study, taking part in a clinical trial for cancer may not actually increase survival.

5.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot